ClinicalTrials.Veeva

Menu

A Study of Brief Behavioral Activation for the Treatment of Depression in Older Adult Cancer Survivors

Memorial Sloan Kettering Cancer Center (MSK) logo

Memorial Sloan Kettering Cancer Center (MSK)

Status and phase

Enrolling
Phase 2

Conditions

Survivorship

Treatments

Behavioral: Supportive Psychotherapy
Behavioral: Behavioral Activation

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of this study is to find out if a psychotherapy method called behavioral activation (BA) can be successfully delivered by telephone or videoconference (remotely) and can effectively treat depression in Older Adult Cancer Survivors (OACS)

Enrollment

90 estimated patients

Sex

All

Ages

65+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • As per self-report or medical record, ≥65 years old

  • As per self-report or medical record, has a history of cancer

  • As per medical record and/or clinician confirmation:

    • a patient in MSK Survivorship Clinics AND/OR
    • no evidence of disease (NED) AND/OR
    • 6 months or more post-treatment (patients on maintenance hormonal therapies are eligible)
  • Fluent in English, as per self-reported fluency of "well" or "very well"*

  • As per self-report, able to communicate over video-conference and/or phone for sessions

  • Elevated score on the PHQ-9: ≥5 (N/A for Training Case participants)

  • Received a Blessed Orientation-Memory-Concentration Scale (BOMC) score of ≤ 11 (N/A for Training Case participants)

Exclusion criteria

  • As per PI determination, requires a higher level of care for current passive or active suicidal ideation than current protocol is able to provide. If a participant receives a score of > 0 on item 9 of the PHQ-9, they will be referred to study PI for further evaluation. They will be excluded from participation in this study if the PI determines they would be appropriate for a higher level of care than BA may be able to provide.
  • As per self-report or as documented in the medical record, current untreated (e.g., no medication, no therapy) major psychotic disorder (schizotypal personality disorder, schizophreniform disorder, schizoaffective disorder). Patients diagnosed with a major psychiatric disorder will be reviewed by the study PI to determine eligibility prior to consent.
  • As per self-report or medical record, currently taking antidepressant medication for < 3 month
  • As per medical record, patient has impaired decision-making capacity

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

90 participants in 2 patient groups

Older Adult Cancer Survivors (OACS) - Behavioral Activation (BA)
Experimental group
Description:
Older adult cancer survivors (OACS) will receive a Behavioral Activation intervention
Treatment:
Behavioral: Behavioral Activation
Older Adult Cancer Survivors (OACS) - Supportive Psychotherapy (SP)
Experimental group
Description:
Older adult cancer survivors (OACS) will receive a Supportive Psychotherapy intervention
Treatment:
Behavioral: Supportive Psychotherapy

Trial contacts and locations

1

Loading...

Central trial contact

Rebecca Saracino, PhD; Christian Nelson, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems